Volume 22, Number 6—June 2016
Dispatch
Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus
Table 2
Serologic responses in 3 infected alpacas, as measured by virus neutralization tests and Luminex bead assays for selected sample days*
Dpi | Serologic results |
No. positive/no. tested)§ |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
VNT titer† |
Luminex assay MFI‡ |
|||||||||
Alpaca 1 | Alpaca 2 | Alpaca 3 | Alpaca 1 | Alpaca 2 | Alpaca 3 | VNT | Luminex | |||
0 | Negative | Negative | Negative | 787 | 889 | 167 | 0/3 | 0/3 | ||
3 | Negative | Negative | Negative | 373 | 814 | 152 | 0/3 | 0/3 | ||
5 | Negative | Negative | Negative | 418 | 945 | 223 | 0/3 | 0/3 | ||
7 | Negative | Negative | Negative | 272 | 932 | 249 | 0/3 | 0/3 | ||
10 | Negative | 1:40 | Negative | 478 | 2,869 | 58 | 1/3 | 1/3 | ||
12 | Negative | 1:40 | Negative | 928 | 10,274 | 331 | 1/3 | 1/3 | ||
14 | Negative | 1:40 | Negative | 1,041 | 7,658 | 899 | 1/3 | 1/3 | ||
21 | 1:10 | 1:40 | Negative | 877 | 6,893 | 629 | 1/3 | 1/3 | ||
24 | 1:20 | 1:20 | Negative | 1,506 | 3,324 | 678 | 2/3 | 1/3 | ||
26 | 1:20 | 1:20 | Negative | 853 | 4,161 | 667 | 2/3 | 1/3 | ||
28 | 1:20 | 1:20 | Negative | 773 | 4,682 | 724 | 2/3 | 1/3 | ||
31 | 1:20 | 1:40 | Negative | 548 | 11,259 | 649 | 2/3 | 1/3 | ||
33 | 1:10 | 1:20 | Negative | 688 | 6,090 | 455 | 1/3 | 1/3 | ||
35§ | 1:10 | NA | Negative | 510 | NA | 586 | 0/2 | 0/2 |
*Bold indicates positive results. Gray shading indicates that >1 animal was positive for the sample collected on that day. Dpi, day postinfection for challenge (initial infection); MFI, median fluorescent intensity; VNT, virus neutralization test.
†The starting dilution was 1:10, and the threshold for a positive result was a dilution of >1:20.
‡The MFI threshold for a positive result for the Luminex assay was 2,500.
§Alpaca 2 was euthanized at day 33, leaving only 2 animals in the study at day 35.
Page created: May 16, 2016
Page updated: May 16, 2016
Page reviewed: May 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.